Thursday’s action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely.
FILE - The anti-viral drug Paxlovid is displayed in New York, Monday, Aug. 1, 2022. Pfizer received full approval for the COVID-19 medication on Thursday, May 25, 2023, winning the U.S. Food and Drug Administration's full endorsement for a drug that has been the go-to treatment against the virus for more than two years. WASHINGTON — Pfizer received full approval on Thursday for its COVID-19 pill Paxlovid that’s been the go-to treatment against the coronavirus.
The decision allows Pfizer’s drug to remain on the market indefinitely and to be marketed similarly to other drugs.The U.S. government has stockpiled millions of doses of Paxlovid and patients will continue to receive it at no charge, the FDA said in a statement. More than 14,000 new COVID-19 cases were reported each week last month, although most U.S. cases are no longer reported to health authorities.
But that doesn’t reflect the U.S. population today, where more than 95% of people have protection from at least one vaccine dose, a prior infection or both.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
FDA Approves New Nasal Spray to Reverse OverdosesThe FDA has approved a second nasal spray for reversing an opioid overdose.
Baca lebih lajut »
FDA approves new drug to reverse opioid overdoseA new nasal spray can reverse the effects of an opioid overdose. The Food and Drug Administration gave its stamp of approval to Opvee, which can be used on patients 12 years and old...
Baca lebih lajut »
FDA Approves Buprenorphine Injection for Opioid Use DisorderThe FDA has approved extended-release injection buprenorphine (Brixadi, Braeburn Inc) for the treatment of moderate to severe opioid use disorder.
Baca lebih lajut »
TransCon PTH Nears US Approval for Hypoparathyroidism?Palopegteriparatide is a potential long-term therapy for adults with hypoparathyroidism, new findings suggest.
Baca lebih lajut »
Over-the-Counter Birth-Control Pills Are Up for FDA Approval. Should You Switch?If the FDA approves it, you could pick up your birth-control pills without visiting your doctor, the same way you buy Tylenol or Advil
Baca lebih lajut »